Globus Medical (GMED) Insider Trading & Ownership $71.81 -0.52 (-0.72%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Globus Medical (NYSE:GMED) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.54%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$15.44 M Get GMED Insider Trade Alerts Want to know when executives and insiders are buying or selling Globus Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GMED Insider Buying and Selling by Quarter Globus Medical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/10/2025Keith W. PfeilCFOSell14,167$88.29$1,250,804.43 12/2/2024Kelly HullerSVPSell2,500$87.00$217,500.00 11/6/2024Daniel T. ScavillaCEOSell60,000$80.02$4,801,200.00 11/6/2024Kelly HullerSVPSell5,000$81.01$405,050.00 10/16/2024David D DavidarDirectorSell30,000$75.04$2,251,200.00 9/13/2024Ann D RhoadsDirectorSell15,000$70.36$1,055,400.00 7/11/2024Leslie V NorwalkDirectorSell1,000$70.00$70,000.00 5/10/2024Dan LemaitreDirectorSell63,300$64.61$4,089,813.00 5/8/2024David D DavidarDirectorSell20,000$65.00$1,300,000.00 (Data available from 1/1/2013 forward) GMED Insider Trading Activity - Frequently Asked Questions Who is on Globus Medical's Insider Roster? The list of insiders at Globus Medical includes Ann D Rhoads, Dan Lemaitre, Daniel T. Scavilla, David D Davidar, Keith W. Pfeil, Kelly Huller, and Leslie V Norwalk. Learn more on insiders at GMED. What percentage of Globus Medical stock is owned by insiders? 18.54% of Globus Medical stock is owned by insiders. Learn more on GMED's insider holdings. Which Globus Medical insiders have been selling company stock? The following insiders have sold GMED shares in the last 24 months: Ann D Rhoads ($1,055,400.00), Dan Lemaitre ($6,565,594.00), Daniel T. Scavilla ($4,801,200.00), David D Davidar ($3,551,200.00), Keith W. Pfeil ($1,250,804.43), Kelly Huller ($622,550.00), and Leslie V Norwalk ($620,574.10). How much insider selling is happening at Globus Medical? Insiders have sold a total of 265,007 Globus Medical shares in the last 24 months for a total of $18,467,322.53 sold. Globus Medical Key ExecutivesMr. David C. Paul (Age 57)Co-Founder & Executive Chairman Compensation: $1.21MMr. Daniel T. Scavilla (Age 59)President, CEO & Director Compensation: $1.67M1 recent tradesMr. Keith W. Pfeil (Age 45)CFO & COO Compensation: $884.04k1 recent tradesMs. Kelly G. Huller Esq. (Age 52)Senior VP, General Counsel & Secretary Compensation: $729.34kMr. Brian J. Kearns (Age 57)Senior Vice President of Business Development & Investor Relations More Insider Trading Tools from MarketBeat Related Companies IDEXX Laboratories Insider Selling ResMed Insider Selling DexCom Insider Selling STERIS Insider Selling Insulet Insider Selling Baxter International Insider Selling Hologic Insider Selling Masimo Insider Selling Teleflex Insider Selling Integer Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold This page (NYSE:GMED) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.